Effectiveness and safety of sofosbuvir plus ribavirin for HCV genotype 2 patients 65 and over with or without cirrhosis

The Kyushu University Liver Disease Study (KULDS) Group

Research output: Contribution to journalArticlepeer-review

33 Citations (Scopus)

Fingerprint Dive into the research topics of 'Effectiveness and safety of sofosbuvir plus ribavirin for HCV genotype 2 patients 65 and over with or without cirrhosis'. Together they form a unique fingerprint.

Medicine & Life Sciences